Searched for
ELEVIDYS
Controversial FDA official Dr Vinay Prasad regains Chief Medical Officer titleDr. Vinayak Prasad has been re-appointed as the FDA's Chief Medical and Scientific Officer and Director of CBER. He will advise senior offi...- Dr Vinay Prasad's FDA exit in less than 3 months linked to Sarepta gene therapy controversy? Check detailsDr. Vinay Prasad, a controversial figure and critic of the FDA, resigned from his high-ranking position at the agency after less than three...
- Vinay Prasad, US FDA's chief medical and science officer, departs agencyVinay Prasad, the Food and Drug Administration's chief medical and science officer, resigned. He cited a desire to return to California and...
- US stock market today dances near record heights: S&P 500 flirts with all-time high, Nasdaq soars on tech euphoria, Dow holds steady as Fed decision loomsUS stock market today trends analysis shows Wall Street moving with cautious optimism as the S&P 500 flirts with record highs and tech stoc...
- US stock market futures surge in record-breaking tsunami as S&P 500, Nasdaq hit all-time highs and Dow rallies ahead of big tech earnings and Fed decisionUS stock market today started the week with rising optimism as Dow Jones, S&P 500, and Nasdaq futures climbed ahead of major earnings repor...
- Sarepta shares fall 7% after gene therapy maker pauses Elevidys shipments in USShares of Sarepta Therapeutics fell nearly 7% on Tuesday after the company agreed to comply with the U.S. health regulator's request to pau...
Load More